{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:08:11Z","timestamp":1782140891867,"version":"3.54.5"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Endometriosis is a benign gynecological disease in which eutopic endometrial tissue composed of glands and stroma grow within the pelvic cavity. The disease affects females of reproductive age and is characterized by pelvic pain, infertility and reduced quality of life. The majority of pharmacologic treatment modalities for endometriosis focus on suppression of estradiol production and\/or action; an approach associated with adverse side effects. c-MYC is elevated in eutopic endometrium and endometriotic lesion tissue in patients with endometriosis and the disease shares many similar pathological characteristics with that of endometrial carcinoma. While targeting of c-MYC with Omomyc has recently gained substantial interest in the field of cancer research, there has been no recent attempt to evaluate the potential utility in targeting c-MYC for endometriosis treatment. The following perspective article compares the similarities between endometriosis and endometrial cancer and presents preliminary data suggesting that targeting c-MYC with Omomyc reduces endometriotic cell proliferation and viability <jats:italic>in vitro<\/jats:italic>. Future application of targeting c-MYC in endometriosis treatment and potential pros and cons are then discussed.<\/jats:p>","DOI":"10.3389\/fcell.2023.1225055","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T14:58:47Z","timestamp":1700751527000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeting c-MYC: a potential non-hormonal therapeutic approach for endometriosis treatment"],"prefix":"10.3389","volume":"11","author":[{"given":"Warren B.","family":"Nothnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachith Polpitiya","family":"Arachchige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Minchella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrm1703","article-title":"Transcriptional regulation and transformation by MYC proteins","volume":"6","author":"Adhikary","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.fertnstert.2003.09.029","article-title":"Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study","volume":"81","author":"Ailawadi","year":"2004","journal-title":"Fertil. Steril."},{"key":"B3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/molehr\/gaz065","article-title":"60S acidic ribosomal protein P1 (RPLP1) is elevated in human endometriotic tissue and in a murine model of endometriosis and is essential for endometriotic epithelial cell survival in vitro","volume":"26","author":"Alali","year":"2020","journal-title":"Mol. Hum. Reprod."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/ijc.31873","article-title":"Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo","volume":"144","author":"Alimova","year":"2019","journal-title":"Int. J. Cancer."},{"key":"B5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.fertnstert.2005.02.018","article-title":"Anastrazole and oral contraceptives: a novel treatment for endometriosis","volume":"84","author":"Amsterdam","year":"2005","journal-title":"Fertil. Steril."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1038\/ncomms5632","article-title":"Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis","volume":"5","author":"Annibali","year":"2014","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.fertnstert.2010.08.042","article-title":"Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue","volume":"95","author":"Bayoglu","year":"2011","journal-title":"Fertil. Steril."},{"key":"B8","doi-asserted-by":"publisher","first-page":"CD002122","DOI":"10.1002\/14651858.CD002122.pub2","article-title":"Progestagens and anti-progestagens for pain associated with endometriosis","volume":"3","author":"Brown","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.32471\/exp-oncology.2312-8852.vol-41-no-2.12973","article-title":"Assessment of HER-2\/neu, \u0441-MYC and\u00a0CCNE1 gene copy number variations and\u00a0protein expression in endometrial carcinomas","volume":"41","author":"Buchynska","year":"2019","journal-title":"Exp. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/humupd\/6.5.413","article-title":"Molecular basis for treating endometriosis with aromatase inhibitors","volume":"6","author":"Bulun","year":"2000","journal-title":"Hum. Reprod. Update"},{"key":"B11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12094-012-0866-3","article-title":"The EMT signaling pathways in endometrial carcinoma","volume":"14","author":"Colas","year":"2012","journal-title":"Clin. Transl. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3390\/ijms23052531","article-title":"Fertility-sparing approaches in atypical endometrial hyperplasia and endometrial cancer patients: current evidence and future directions","volume":"235","author":"Contreras","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum. Reprod."},{"key":"B14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/s0015-0282(00)01759-3","article-title":"Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis","volume":"75","author":"Fedele","year":"2001","journal-title":"Fertil. Steril."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/humrep\/dez053","article-title":"Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals a differential transcriptomic profile associated with lower quality","volume":"34","author":"Ferrero","year":"2019","journal-title":"Hum. Reprod."},{"key":"B16","doi-asserted-by":"publisher","first-page":"31014","DOI":"10.18632\/oncotarget.8826","article-title":"Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation","volume":"7","author":"Fiorentino","year":"2016","journal-title":"Oncotarget"},{"key":"B17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study","volume":"20","author":"Geisler","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1048-891x.2004.14027.x","article-title":"Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival","volume":"14","author":"Geisler","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/S0140-6736(22)00622-5","article-title":"Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)","volume":"399","author":"Giudice","year":"2022","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","article-title":"Endometriosis","volume":"364","author":"Giudice","year":"2004","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1007\/s10815-020-01905-4","article-title":"GRN, NOTCH3, FN1, and PINK1 expression in eutopic endometrium \u2013 potential biomarkers in the detection of endometriosis \u2013 a pilot study","volume":"37","author":"Holzer","year":"2020","journal-title":"J. Assist. Reprod. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00210-022-02365-6","article-title":"Focus on the role of NLRP3 inflammasome in the pathology of endometriosis: a review on molecular mechanisms and possible medical applications","volume":"396","author":"Irandoost","year":"2023","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1126\/science.1071489","article-title":"Sustained loss of a neoplastic phenotype by brief inactivation of MYC","volume":"297","author":"Jain","year":"2002","journal-title":"Science"},{"key":"B25","first-page":"335","article-title":"Endometriosis: pathogenetic implications of the anatomic distribution","volume":"67","author":"Jenkins","year":"1986","journal-title":"Obstet. Gynecol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1477-7827-3-45","article-title":"Augmented cell survival in eutopic endometrium from women with endometriosis: expression of c-myc, TGF-beta1 and bax genes","volume":"3","author":"Johnson","year":"2005","journal-title":"Reprod. Biol. Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ygyno.2008.10.032","article-title":"Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer","volume":"112","author":"Jongen","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e29023","DOI":"10.1097\/MD.0000000000029023","article-title":"Long-term efficacy and safety of levonorgestrel-releasing intrauterine system as a maintenance treatment for endometriosis","volume":"101","author":"Kim","year":"2022","journal-title":"Medicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids and breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Endocr. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/humrep\/den484","article-title":"Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis","volume":"24","author":"Kim","year":"2009","journal-title":"Hum. Reprod."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/jcm9061915","article-title":"Epithelial-mesenchymal transition in endometriosis-when does it happen?","volume":"9","author":"Konrad","year":"2020","journal-title":"J. Clin. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0138515","DOI":"10.1371\/journal.pone.0138515","article-title":"SALL4 as an epithelial-mesenchymal transition and drug resistance inducer through the regulation of c-Myc in endometrial cancer","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.2147\/OTT.S218240","article-title":"NLRP3 inflammasome activation by estrogen promotes the progression of human endometrial cancer","volume":"12","author":"Liu","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00432-012-1249-4","article-title":"N-myc downstream-regulated gene 1\/Cap43 may function as tumor suppressor in endometrial cancer","volume":"138","author":"Lv","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/cells11040647","article-title":"Progesterone actions and resistance in gynecological disorders","volume":"11","author":"MacLean","year":"2022","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/cells9040883","article-title":"Blocking Myc to treat cancer: reflecting on two decades of Omomyc","volume":"9","author":"Masso-Valles","year":"2020","journal-title":"Cells"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1093\/humrep\/det346","article-title":"Consensus on current management of endometriosis","volume":"28","author":"Menakaya","year":"2013","journal-title":"Hum. Reprod."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.humpath.2013.04.009","article-title":"Epithelial-to-mesenchymal transition and stem cells in endometrial cancer","volume":"44","author":"Mirantes","year":"2013","journal-title":"Hum. Pathol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/prca.200900055","article-title":"Identification of anti-\u03b1-enolase autoantibody as a novel serum marker for endometriosis","volume":"10","author":"Nabeta","year":"2009","journal-title":"Proteomics Clin. Appl."},{"key":"B40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/1573404813666161221164810","article-title":"Future directions in endometriosis research and therapeutics","volume":"14","author":"Nothnick","year":"2018","journal-title":"Curr. Womens Health Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12967-022-03545-x","article-title":"The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer","volume":"20","author":"Pang","year":"2022","journal-title":"J. Transl. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jnutbio.2019.02.006","article-title":"Ameliorative effects of luteolin against endometriosis progression in vitro and in vivo","volume":"67","author":"Park","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"108328","DOI":"10.1016\/j.jnutbio.2019.108328","article-title":"Myricetin inhibits endometriosis growth through cyclin E1 down-regulation in vitro and in vivo","volume":"78","author":"Park","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/aogs.13156","article-title":"Progesterone resistance in endometriosis: origins, consequences and interventions","volume":"96","author":"Patel","year":"2017","journal-title":"Acta. Obstet. Gynecol. Scand."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.fertnstert.2012.06.056","article-title":"The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis","volume":"98","author":"Pellegrini","year":"2012","journal-title":"Fertil. Steril."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3390\/ijms24032690","article-title":"RPLP1 is up-regulated in human adenomyosis and endometrial adenocarcinoma epithelial cells and is essential for cell survival and migration in vitro","volume":"24","author":"Peterson","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/bmj.323.7304.93","article-title":"Regular review: endometriosis","volume":"323","author":"Prentice","year":"2001","journal-title":"Br. Med. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12958-015-0063-7","article-title":"Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis","volume":"13","author":"Proestling","year":"2015","journal-title":"Reprod. Biol. Endocrinol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"66809","DOI":"10.18632\/oncotarget.11631","article-title":"JQ1 suppresses tumor growth via PTEN\/PI3K\/AKT pathway in endometrial cancer","volume":"7","author":"Qiu","year":"2016","journal-title":"Oncotarget"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/jcm12031008","article-title":"Gonadotropin-releasing hormone antagonists \u2013 a new hope in endometriosis treatment?","volume":"12","author":"Rzewuska","year":"2023","journal-title":"J. Clin. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1349-7006.2006.00332.x","article-title":"Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma","volume":"97","author":"Saito","year":"2006","journal-title":"Cancer Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/s0002-9378(15)30003-x","article-title":"Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity","volume":"14","author":"Sampson","year":"1927","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/0002-9378(91)90580-k","article-title":"c-myc protooncogene polypeptide expression in endometriosis","volume":"164","author":"Schenken","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/or.5.1.49","article-title":"c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis","volume":"5","author":"Schneider","year":"1998","journal-title":"Oncol. Rep."},{"key":"B55","first-page":"257","article-title":"GnRH analogues in the treatment of endometriosis-rationale and efficacy","volume-title":"Modern approaches to endometriosis","author":"Shaw","year":"1990"},{"key":"B56","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1158\/2159-8290.CD-19-0435","article-title":"MYC instructs and maintains pancreatic adenocarcinoma phenotype","volume":"19","author":"Sodir","year":"2020","journal-title":"Cancer Discov."},{"key":"B57","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1101\/gad.2038411","article-title":"Endogenous Myc maintains the tumor microenvironment","volume":"25","author":"Sodir","year":"2011","journal-title":"Genes Dev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/sj.cdd.4401443","article-title":"Omomyc expression in skin prevents Myc-induced papillomatosis","volume":"11","author":"Soucek","year":"2004","journal-title":"Cell Death Differ."},{"key":"B59","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nature07260","article-title":"Modelling Myc inhibition as a cancer therapy","volume":"455","author":"Soucek","year":"2008","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1101\/gad.205542.112","article-title":"Inhibition of Myc family proteins eradicates Kras-driven lung cancer in mice","volume":"27","author":"Soucek","year":"2013","journal-title":"Genes Dev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"179515","DOI":"10.1155\/2014\/179515","article-title":"Theories on the pathogenesis of endometriosis","volume":"2014","author":"Sourial","year":"2014","journal-title":"Int. J. Reprod. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/GCO.0b013e32833b35a7","article-title":"Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?","volume":"22","author":"Surrey","year":"2010","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"B63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1155\/2014\/757534","article-title":"Mammalian MYC proteins and cancer","volume":"2014","author":"Tansey","year":"2014","journal-title":"New J. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000052876","article-title":"Proliferative activity and genetic alterations in TP53 in endometriosis","volume":"50","author":"Toki","year":"2000","journal-title":"Gynecol. Obstet. Invest."},{"key":"B65","doi-asserted-by":"publisher","first-page":"906570","DOI":"10.3389\/fendo.2022.906570","article-title":"Dysregulated sphingolipid metabolism and autophagy in granulosa cells of women with endometriosis","volume":"13","author":"Turathum","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"B66","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41392-021-00500-y","article-title":"Alternative approaches to target Myc for cancer treatment","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"B67","doi-asserted-by":"publisher","first-page":"41679","DOI":"10.18632\/oncotarget.16472","article-title":"Epithelial-to-mesenchymal transition in the development of endometriosis","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3390\/curroncol30020142","article-title":"Risk of cardiovascular events and lipid profile change in patients with breast cancer taking aromatase inhibitor: a systematic review and meta-analysis","volume":"30","author":"Yoo","year":"2023","journal-title":"Curr. Oncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/IGC.0000000000000384","article-title":"Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study","volume":"25","author":"Yu","year":"2015","journal-title":"Int. J. Gynecol. Cancer."},{"key":"B70","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1186\/gb-2003-4-10-r69","article-title":"An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets","volume":"4","author":"Zeller","year":"2003","journal-title":"Genome Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.12659\/MSM.908812","article-title":"Correlation of MACC1\/c-myc expression in endometrial carcinoma with clinical\/pathological features or prognosis","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3892\/mmr.2021.12276","article-title":"Hypoxia-induced lactate dehydrogenase A protects cells from apoptosis in endometriosis","volume":"24","author":"Zheng","year":"2021","journal-title":"Mol. Med. Rep."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1225055\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T14:58:52Z","timestamp":1700751532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1225055\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":72,"alternative-id":["10.3389\/fcell.2023.1225055"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2023.1225055","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]},"article-number":"1225055"}}